COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1- Antitrypsin (AAT) Combined with Corticosteroids vs. Corticosteroids Alone for the Treatment of High-Risk Acute Graft-versus-Host-Disease (GVHD) Following Hematopoietic Stem Cell Transplant

Protocol No
CTN-1705
Principal Investigator
Sameem Abedin
Phase
III
Summary
This study is to see if a drug called Alpha 1-Antitrypsin (AAT), along with corticosteroids, helps treat the effects of Graft-Versus-Host-Disease (GVHD).
Description
Alpha 1- Antitrypsin Combined with Corticosteroids vs. Corticosteroids Alone for Tx of aGVHD
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL